MicroRNA dysregulation as a prognostic biomarker in wild-type RAS/RAF/PTEN/PI3 metastatic colon cancer treated with anti-EGFRtherapeutics


AK S., TUNCA B., ERTAŞ H., UĞRAŞ N., ÖZTÜRK E., YILMAZLAR A. T. , ...More

TAT 2018 – Targeted Anticancer Therapies, 5 - 07 March 2018

  • Publication Type: Conference Paper / Summary Text